Engineering the gut-brain connection for the future of mental health with psychobiotics

The gut-brain axis is a dynamic, bidirectional communication system connecting the central nervous system with the enteric nervous system. It regulates digestion, cognition, mood, and immune responses and plays an important role in neuropsychiatric and gastrointestinal disorders. Psychobiotics are described as live organisms that interact with the gut-brain axis to improve mental health in the host when consumed in sufficient amounts. This review outlines the mechanism through which psychobiotics will exert their effects, including neurotransmitter modulation (e.g., serotonin, GABA), regulation of the hypothalamic-pituitary-adrenal axis, inhibition of neuroinflammation and oxidative stress, restoration of intestinal barrier integrity, and production of neuroactive microbial metabolites such as short-chain fatty acids and tryptophan derivatives. Advances in psychobiotics include engineered microbial strains, targeted delivery systems, personalized therapies, and combination therapies improving mental health. Despite these advances, challenges such as individual differences, regulatory issues, and ethical concerns persist. Continued clinical research is needed to confirm that the psychobiotics are safe and effective for the treatment of psychiatric and neurodevelopmental disorders.